Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, CCR7 | 7 | 2025 | 19 | 2.940 |
Why?
|
| Chemokine CCL19 | 4 | 2025 | 10 | 2.460 |
Why?
|
| T-Lymphocytes | 5 | 2025 | 386 | 1.420 |
Why?
|
| Type C Phospholipases | 2 | 2020 | 23 | 0.990 |
Why?
|
| Chemokine CCL21 | 4 | 2024 | 14 | 0.930 |
Why?
|
| Adaptive Immunity | 1 | 2025 | 34 | 0.930 |
Why?
|
| Immunity, Humoral | 1 | 2025 | 29 | 0.920 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 9 | 0.880 |
Why?
|
| Chemokines, CC | 1 | 2022 | 55 | 0.710 |
Why?
|
| Signal Transduction | 8 | 2025 | 2157 | 0.640 |
Why?
|
| Biological Products | 1 | 2021 | 91 | 0.630 |
Why?
|
| Arrestins | 5 | 2008 | 28 | 0.610 |
Why?
|
| Antiviral Agents | 1 | 2021 | 195 | 0.610 |
Why?
|
| Chemotaxis | 4 | 2024 | 68 | 0.560 |
Why?
|
| Cell Degranulation | 2 | 2004 | 10 | 0.410 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2012 | 108 | 0.410 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2012 | 105 | 0.400 |
Why?
|
| Animals | 18 | 2025 | 16992 | 0.390 |
Why?
|
| Receptors, Formyl Peptide | 5 | 2005 | 7 | 0.380 |
Why?
|
| Mice | 10 | 2025 | 6644 | 0.370 |
Why?
|
| Receptors, Lysosphingolipid | 1 | 2012 | 4 | 0.370 |
Why?
|
| Phospholipase C gamma | 1 | 2010 | 9 | 0.330 |
Why?
|
| Endocytosis | 3 | 2008 | 118 | 0.330 |
Why?
|
| Fibronectins | 1 | 2010 | 69 | 0.320 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1723 | 0.320 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 166 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 1869 | 0.280 |
Why?
|
| Dendritic Cells | 3 | 2013 | 132 | 0.260 |
Why?
|
| Mast Cells | 2 | 2004 | 82 | 0.250 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2004 | 93 | 0.250 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1070 | 0.250 |
Why?
|
| Mice, Knockout | 3 | 2025 | 1035 | 0.250 |
Why?
|
| Isoenzymes | 2 | 2020 | 168 | 0.240 |
Why?
|
| Humans | 15 | 2024 | 43102 | 0.230 |
Why?
|
| Cell Movement | 2 | 2024 | 655 | 0.230 |
Why?
|
| Immunoglobulin G | 1 | 2025 | 259 | 0.210 |
Why?
|
| Phosphorylation | 6 | 2012 | 986 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 2 | 2015 | 8 | 0.210 |
Why?
|
| Leukocytes | 1 | 2004 | 80 | 0.210 |
Why?
|
| Central Nervous System | 1 | 2024 | 152 | 0.200 |
Why?
|
| Neoplasm Invasiveness | 1 | 2024 | 290 | 0.200 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2002 | 6 | 0.200 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2014 | 55 | 0.190 |
Why?
|
| Receptors, Peptide | 1 | 2002 | 24 | 0.190 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 73 | 0.190 |
Why?
|
| Peptide Fragments | 2 | 2014 | 307 | 0.180 |
Why?
|
| Lymph Nodes | 1 | 2022 | 74 | 0.180 |
Why?
|
| Immunity | 1 | 2021 | 61 | 0.170 |
Why?
|
| Cell Line, Tumor | 2 | 2024 | 2676 | 0.170 |
Why?
|
| Peptides | 3 | 2014 | 372 | 0.170 |
Why?
|
| Cell Physiological Phenomena | 1 | 2020 | 9 | 0.160 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 259 | 0.150 |
Why?
|
| Lead Poisoning, Nervous System, Childhood | 1 | 2019 | 9 | 0.150 |
Why?
|
| Organometallic Compounds | 1 | 2019 | 71 | 0.150 |
Why?
|
| Hyaluronic Acid | 2 | 2014 | 36 | 0.130 |
Why?
|
| Microglia | 1 | 2019 | 208 | 0.130 |
Why?
|
| Immune Tolerance | 2 | 2014 | 68 | 0.130 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1604 | 0.130 |
Why?
|
| Cells, Cultured | 5 | 2014 | 1621 | 0.120 |
Why?
|
| TNF Receptor-Associated Factor 4 | 1 | 2015 | 1 | 0.120 |
Why?
|
| Cell Line | 3 | 2012 | 1410 | 0.120 |
Why?
|
| Hippocampus | 1 | 2019 | 594 | 0.120 |
Why?
|
| Female | 4 | 2025 | 24698 | 0.120 |
Why?
|
| Interleukin-17 | 1 | 2015 | 53 | 0.120 |
Why?
|
| Transfection | 4 | 2004 | 532 | 0.110 |
Why?
|
| Keratinocytes | 1 | 2015 | 67 | 0.110 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2014 | 12 | 0.110 |
Why?
|
| Autoantigens | 1 | 2014 | 87 | 0.100 |
Why?
|
| Ovalbumin | 1 | 2013 | 47 | 0.100 |
Why?
|
| Antigen-Presenting Cells | 1 | 2013 | 31 | 0.100 |
Why?
|
| Protein Binding | 3 | 2008 | 1082 | 0.100 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2013 | 59 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 665 | 0.100 |
Why?
|
| Drug Carriers | 1 | 2014 | 174 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 2 | 2012 | 423 | 0.100 |
Why?
|
| Polymers | 1 | 2013 | 155 | 0.090 |
Why?
|
| Lysophospholipids | 1 | 2012 | 20 | 0.090 |
Why?
|
| Phosphatidylinositols | 1 | 2012 | 13 | 0.090 |
Why?
|
| Sphingosine | 1 | 2012 | 22 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 60 | 0.090 |
Why?
|
| Ligands | 3 | 2008 | 388 | 0.090 |
Why?
|
| Membrane Proteins | 2 | 2015 | 561 | 0.090 |
Why?
|
| Autoimmune Diseases | 1 | 2011 | 65 | 0.080 |
Why?
|
| Blood-Brain Barrier | 1 | 2011 | 173 | 0.080 |
Why?
|
| Chemokines | 1 | 2010 | 96 | 0.080 |
Why?
|
| Receptor Aggregation | 1 | 2008 | 2 | 0.070 |
Why?
|
| Nanostructures | 1 | 2011 | 161 | 0.070 |
Why?
|
| Protein Transport | 3 | 2005 | 296 | 0.070 |
Why?
|
| Gene Expression | 1 | 2012 | 701 | 0.070 |
Why?
|
| Jurkat Cells | 1 | 2008 | 87 | 0.070 |
Why?
|
| Proteins | 1 | 2011 | 382 | 0.070 |
Why?
|
| Phosphoproteins | 2 | 2015 | 206 | 0.070 |
Why?
|
| Arrestin | 2 | 2004 | 8 | 0.060 |
Why?
|
| HL-60 Cells | 2 | 2004 | 33 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 436 | 0.060 |
Why?
|
| Inflammation | 1 | 2011 | 758 | 0.060 |
Why?
|
| Kinetics | 2 | 2005 | 695 | 0.060 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 53 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 256 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 135 | 0.050 |
Why?
|
| Time Factors | 3 | 2019 | 1857 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 508 | 0.040 |
Why?
|
| Cytokines | 2 | 2014 | 678 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 31 | 0.040 |
Why?
|
| Lactation | 1 | 2019 | 44 | 0.040 |
Why?
|
| Drug Delivery Systems | 2 | 2011 | 277 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2019 | 352 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2019 | 456 | 0.030 |
Why?
|
| Apoptosis | 1 | 2004 | 1568 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2015 | 9 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 32 | 0.030 |
Why?
|
| Macrophages | 1 | 2019 | 529 | 0.030 |
Why?
|
| Rats | 1 | 2002 | 3735 | 0.030 |
Why?
|
| U937 Cells | 2 | 2005 | 31 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2014 | 114 | 0.030 |
Why?
|
| Solubility | 1 | 2014 | 139 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2015 | 192 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2005 | 224 | 0.030 |
Why?
|
| Spleen | 1 | 2014 | 204 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2005 | 209 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 186 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 213 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2015 | 178 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 74 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2013 | 249 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2013 | 184 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 458 | 0.020 |
Why?
|
| Immunological Synapses | 1 | 2011 | 1 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 238 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1455 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 355 | 0.020 |
Why?
|
| Quinolinium Compounds | 1 | 2005 | 9 | 0.010 |
Why?
|
| Point Mutation | 1 | 2005 | 98 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2004 | 27 | 0.010 |
Why?
|
| Propidium | 1 | 2004 | 20 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2004 | 30 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 2004 | 59 | 0.010 |
Why?
|
| Cytochromes c | 1 | 2004 | 48 | 0.010 |
Why?
|
| Multigene Family | 1 | 2004 | 105 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2005 | 184 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 196 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2005 | 182 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 148 | 0.010 |
Why?
|
| Brain | 1 | 2011 | 1472 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 296 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 311 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 227 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2004 | 416 | 0.010 |
Why?
|
| Cell Death | 1 | 2004 | 278 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 462 | 0.010 |
Why?
|
| Cholesterol | 1 | 2004 | 232 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2004 | 281 | 0.010 |
Why?
|
| Lipids | 1 | 2004 | 256 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 1180 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2004 | 403 | 0.010 |
Why?
|
| Calcium | 1 | 2004 | 491 | 0.010 |
Why?
|
| Mitochondria | 1 | 2004 | 523 | 0.010 |
Why?
|
| Male | 1 | 2019 | 23409 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 1177 | 0.010 |
Why?
|